Elsevier Launches New Open Access Journal:Case Reports in Women’s Health

May 29, 2014

AMSTERDAM, May 29, 2014 /PRNewswire/ –

Elsevier’s 100th open access title now available on ScienceDirect

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and solutions, today announced the launch of a new open
access journal: Case Reports in Women’s Health
[http://www.sciencedirect.com/science/journal/aip/22149112 ].

Case Reports in Women’s Health publishes open access case reports covering all aspects
of women’s health. The scope reflects the comprehensive nature of women’s health and
includes not only the core areas of obstetrics and gynecology, but also the key
subspecialty areas.

Editor-in-Chief Stephen L. Corson said, “We believe that case reports serve a vital
function in the literature by acting as ‘the canary in the coal mine’. Case Reports are
detailed medical reports of the symptoms, diagnosis, treatment and follow-up of an
individual patient. They often contain a demographic profile of the patient and describe a
unique or novel occurrence. Many emerging diseases and conditions caused by a physician or
healthcare environment due to exposure to pathogens, toxins or harmful procedures first
appeared as case reports. Our aim is to be the most comprehensive source of informative
case reports for busy clinicians and professionals in the diverse and growing field of
women’s health.”

Stephen L. Corson is Professor Emeritus of Obstetrics and Gynecology at Thomas
Jefferson University School of Medicine, Philadelphia, USA and Editor Emeritus of
Elsevier’s Journal of Minimally Invasive Gynecology. He is supported by a team of eight
editors who are leading experts in their specialties.

Greyling Peoples, the Publisher responsible for Elsevier’s Women’s Health journal
portfolio, said, “Our program aims to publish the best research and clinical developments
in the field of women’s health, and continue to make this content universally accessible,
offer new publishing options for our authors. Case Reports in Woman’s Health is a great
addition to the program.”

For more information or to submit an article please go to


About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish open access in over 1,600 established peer-reviewed
journals as well as 100 full open access journals and these numbers will continue to grow
rapidly. All of Elsevier’s open access publications have been peer reviewed, ensuring that
the broader community not only reads the latest research but that it is factual, original
and of the highest quality and ethical standards. For more information about Elsevier’s
open access program, visit http://www.elsevier.com/openaccess.

About Elsevier

Elsevier [http://www.elsevier.com ] is a world-leading provider of information
solutions that enhance the performance of science, health, and technology professionals,
empowering them to make better decisions, deliver better care, and sometimes make
groundbreaking discoveries that advance the boundaries of knowledge and human progress.
Elsevier provides web-based, digital solutions – among them ScienceDirect, Scopus
[http://www.scopus.com ], Elsevier Research Intelligence
[http://www.elsevier.com/online-tools/research-intelligence ], and ClinicalKey
[https://www.clinicalkey.com ] – and publishes nearly 2,200 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and over 25,000 book titles,
including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a world
leading provider of professional information solutions in the Science, Medical, Legal and
Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier
NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).

        Media contact
        Greyling Peoples

SOURCE Elsevier

Source: PR Newswire

comments powered by Disqus